Literature DB >> 25899244

Cerebral computed tomography-graded white matter lesions are associated with worse outcome after thrombolysis in patients with stroke.

Sami Curtze1, Susanna Melkas2, Gerli Sibolt2, Elena Haapaniemi2, Satu Mustanoja2, Jukka Putaala2, Tiina Sairanen2, Marjaana Tiainen2, Turgut Tatlisumak2, Daniel Strbian2.   

Abstract

BACKGROUND AND
PURPOSE: Compared with other stroke causes, small-vessel disease is associated with better 3-month outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. Another question is the impact of coexisting cerebral white matter lesions (WMLs; a surrogate marker of small-vessel disease) on outcome, which was addressed in the current study.
METHODS: We analyzed 2485 consecutive intravenous thrombolysis-treated patients at the Helsinki University Central Hospital, 2001 to 2014. WMLs were scored according to 4 previously published computed tomographic visual rating scales from all baseline head scans. The inter-rater agreement was calculated. The primary outcome measure was shift analysis, and the secondary examined all possible binary cutoffs in the modified Rankin Scale at 3 months. The associations of modified Rankin Scale with nominal, ordinal, and continuous variables were analyzed in univariate and adjusted in multivariate binary and ordinal regression (shift analysis) models.
RESULTS: In univariate and multivariate regression analyses, all 4 tested visual WML rating scales (as continuous variables, or dichotomized at different cutoff points) were associated with worse outcome at all binary levels and in shift analyses of the modified Rankin Scale. After adjusting for confounders, the statistically strongest association in shift analyses remained for the Blennow scale dichotomized at >3 points, reflecting at least moderate WMLs (odds ratio, 1.90; 95% confidence interval, 1.48-2.44).
CONCLUSIONS: WMLs on admission computed tomographic scan are independently associated with worse outcome in intravenous thrombolysis-treated patients with stroke.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  outcome measures; thrombolytic therapy

Mesh:

Year:  2015        PMID: 25899244     DOI: 10.1161/STROKEAHA.115.008941

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

Review 1.  Recent Advances in Leukoaraiosis: White Matter Structural Integrity and Functional Outcomes after Acute Ischemic Stroke.

Authors:  Mark R Etherton; Ona Wu; Natalia S Rost
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

2.  Heterogeneity of Astrocytes in Grey and White Matter.

Authors:  Susanne Köhler; Ulrike Winkler; Johannes Hirrlinger
Journal:  Neurochem Res       Date:  2019-12-03       Impact factor: 3.996

3.  Small Vessel Disease Is Associated with Tissue Inhibitor of Matrix Metalloproteinase-4 After Ischaemic Stroke.

Authors:  Francesco Arba; Benedetta Piccardi; Vanessa Palumbo; Betti Giusti; Patrizia Nencini; Anna Maria Gori; Alice Sereni; Mascia Nesi; Giovanni Pracucci; Giorgio Bono; Paolo Bovi; Enrico Fainardi; Domenico Consoli; Antonia Nucera; Francesca Massaro; Giovanni Orlandi; Francesco Perini; Rossana Tassi; Maria Sessa; Danilo Toni; Rosanna Abbate; Domenico Inzitari
Journal:  Transl Stroke Res       Date:  2018-04-23       Impact factor: 6.829

4.  Impact of leukoaraiosis on parenchymal hemorrhage in elderly patients treated with thrombolysis.

Authors:  Norbert Nighoghossian; Fatima Abbas; Tae-Hee Cho; Ana Filipa Geraldo; Vincent Cottaz; Elie Janecek; Laura Mechtouff; Magali Bischoff; Carlos El Khoury; Anne Marie Schott; Laurent Derex; Marc Hermier; Louis Guy Tisserand; Roxana Amelie; Leila Chamard; Yves Berthezene
Journal:  Neuroradiology       Date:  2016-07-22       Impact factor: 2.804

5.  Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).

Authors:  Andreas Charidimou; Marco Pasi; Marco Fiorelli; Sara Shams; Rüdiger von Kummer; Leonardo Pantoni; Natalia Rost
Journal:  Stroke       Date:  2016-08-04       Impact factor: 7.914

Review 6.  White matter injury in ischemic stroke.

Authors:  Yuan Wang; Gang Liu; Dandan Hong; Fenghua Chen; Xunming Ji; Guodong Cao
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

Review 7.  CK2 inhibition protects white matter from ischemic injury.

Authors:  Selva Baltan; Chinthasagar Bastian; John Quinn; Danielle Aquila; Andrew McCray; Sylvain Brunet
Journal:  Neurosci Lett       Date:  2018-08-17       Impact factor: 3.197

8.  Chronic kidney disease and poor outcomes in ischemic stroke: is impaired cerebral autoregulation the missing link?

Authors:  Pedro Castro; Elsa Azevedo; Isabel Rocha; Farzaneh Sorond; Jorge M Serrador
Journal:  BMC Neurol       Date:  2018-03-02       Impact factor: 2.474

9.  Association between the extent of white matter damage and early cognitive impairment following acute ischemic stroke.

Authors:  Jian Li; Yong Zhao; Jinying Mao
Journal:  Exp Ther Med       Date:  2017-01-11       Impact factor: 2.447

10.  Increased Risk of Post-Thrombolysis Intracranial Hemorrhage in Acute Ischemic Stroke Patients with Leukoaraiosis: A Meta-Analysis.

Authors:  Qianqian Lin; Zhong Li; Rui Wei; Qingfeng Lei; Yunyun Liu; Xiaodong Cai
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.